Rite Aid: Q1 Earnings Insights

Shares of Rite Aid RAD moved higher by 28.6% after the company reported Q1 results.

Quarterly Results

Earnings per share increased 71.43% year over year to ($0.04), which beat the estimate of ($0.38).

Revenue of

Shares of Rite Aid RAD moved higher by 28.6% after the company reported Q1 results.

Quarterly Results

Earnings per share increased 71.43% year over year to ($0.04), which beat the estimate of ($0.38).

Revenue of $6,027,000,000 up by 12.17% year over year, which beat the estimate of $5,610,000,000.

Outlook

Rite Aid hasn't issued any earnings guidance for the time being.

Revenue guidance hasn't been issued by the company for now.

Technicals

52-week high: $23.88

Company's 52-week low was at $5.04

Price action over last quarter: Up 41.49%

Company Overview

Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal-care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Earnings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!